News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BIOTECHNOLOGY VALUE FUND L P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/28/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Unknown transaction of 3,989,130 shares
@ $9.1, valued at
$36.3M
Unknown transaction of 2,595,239 shares
@ $9.1, valued at
$23.6M
Unknown transaction of 702,505 shares
@ $9.1, valued at
$6.4M
Unknown transaction of 1,526,147 shares
@ $9.1, valued at
$13.9M
Unknown transaction of 43,139 shares
@ $9.1, valued at
$392.6k
Unknown transaction of 1,594 options to buy
@ $0
Unknown transaction of 1,250 options to buy
@ $0
Unknown transaction of 191 options to buy
@ $0
Unknown transaction of 12 options to buy
@ $0
Unknown transaction of 344 options to buy
@ $0
Unknown transaction of 239 options to buy
@ $0 |
|
| 06/12/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Granted 11,297 options to buy
@ $29.18, valued at
$329.6k
|
|
| 05/19/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 10,967 options to buy
@ $21.39, valued at
$234.6k
|
|
| 05/12/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Disposed of 4,018,253 shares
@ $0
Disposed of 2,929,660 shares
@ $0
Disposed of 462,605 shares
@ $0
Acquired 4,018,253 options to buy
@ $0
Acquired 2,929,660 options to buy
@ $0
Acquired 462,605 options to buy
@ $0 |
|
| 05/09/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Eledon Pharmaceuticals, Inc.|
Txns:
| Bought 1,055,445 shares
@ $0
Bought 837,146 shares
@ $0
Bought 86,341 shares
@ $0
Bought 2,028,645 options to buy
@ $0.001, valued at
$2k
Bought 1,609,063 options to buy
@ $0.001, valued at
$1.6k
Bought 165,950 options to buy
@ $0.001, valued at
$166
Bought 3,084,090 options to buy
@ $3, valued at
$9.3M
Bought 2,446,209 options to buy
@ $3, valued at
$7.3M
Bought 252,291 options to buy
@ $3, valued at
$756.9k
|
|
| 01/19/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Disposed of 3,500,000 shares
@ $0
Disposed of 2,600,000 shares
@ $0
Disposed of 300,000 shares
@ $0
Acquired 350,000 options to buy
@ $0
Acquired 260,000 options to buy
@ $0
Acquired 30,000 options to buy
@ $0 |
|
| 01/09/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 3,330 shares
@ $18.3852, valued at
$61.2k
Bought 1,676 shares
@ $21.9817, valued at
$36.8k
Bought 15,670 shares
@ $18.3852, valued at
$288.1k
Bought 1,573 shares
@ $21.9817, valued at
$34.6k
|
|
| 12/22/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Third Harmonic Bio, Inc.|
Txns:
| Bought 116,635 shares
@ $4.1086, valued at
$479.2k
Bought 87,831 shares
@ $4.1086, valued at
$360.9k
Bought 9,597 shares
@ $4.1086, valued at
$39.4k
|
|
| 11/10/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 970,171 shares
@ $5.83, valued at
$5.7M
Bought 685,330 shares
@ $5.83, valued at
$4M
Bought 54,857 shares
@ $5.83, valued at
$319.8k
|
|
| 09/27/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 6,715 shares
@ $16.497, valued at
$110.8k
Bought 3,339 shares
@ $16.8317, valued at
$56.2k
Bought 1,004 shares
@ $16.8902, valued at
$17k
Bought 9,885 shares
@ $16.497, valued at
$163.1k
Bought 3,021 shares
@ $16.8317, valued at
$50.8k
Bought 678 shares
@ $16.8902, valued at
$11.5k
|
|
| 09/16/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Bought 26,441 shares
@ $17.2476, valued at
$456k
Bought 5,575 shares
@ $17.962, valued at
$100.1k
Bought 10,897 shares
@ $17.8873, valued at
$194.9k
Bought 13,396 shares
@ $17.8873, valued at
$239.6k
|
|
| 08/23/2022 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 285,046 shares
@ $26, valued at
$7.4M
Bought 233,362 shares
@ $26, valued at
$6.1M
Bought 27,117 shares
@ $26, valued at
$705k
|
|
| 08/11/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Sold 3,850,803 shares
@ $6.12, valued at
$23.6M
Converted 3,754,000 shares
@ $0
Sold 2,890,723 shares
@ $6.12, valued at
$17.7M
Converted 2,426,666 shares
@ $0
Sold 469,040 shares
@ $6.12, valued at
$2.9M
Converted 682,666 shares
@ $0
Sold 1,289,434 shares
@ $6.12, valued at
$7.9M
Converted 1,519,999 shares
@ $0
Converted 5,631 options to buy
@ $0
Converted 3,640 options to buy
@ $0
Converted 1,024 options to buy
@ $0 |
|
| 06/17/2022 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $14.18, valued at
$170.2k
|
|
| 06/15/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Bought 74,666 shares
@ $12.73, valued at
$950.5k
Bought 68,327 shares
@ $12.73, valued at
$869.8k
Bought 6,168 shares
@ $12.73, valued at
$78.5k
|
|
| 06/14/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 158,583 shares
@ $4.0345, valued at
$639.8k
Bought 41,417 shares
@ $4.0345, valued at
$167.1k
|
|
| 06/06/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Bought 660,654 shares
@ $11.6824, valued at
$7.7M
Bought 353,344 shares
@ $12.286, valued at
$4.3M
Bought 3,809 shares
@ $13.2118, valued at
$50.3k
Bought 464,235 shares
@ $11.6824, valued at
$5.4M
Bought 258,797 shares
@ $12.286, valued at
$3.2M
Bought 3,040 shares
@ $13.2118, valued at
$40.2k
Bought 61,156 shares
@ $11.6824, valued at
$714.4k
Bought 31,903 shares
@ $12.286, valued at
$392k
Bought 20 shares
@ $13.2118, valued at
$264.2 |
|
| 06/03/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Bought 405,641 shares
@ $10.9994, valued at
$4.5M
Bought 301,009 shares
@ $10.9994, valued at
$3.3M
Bought 44,746 shares
@ $10.9994, valued at
$492.2k
|
|
| 05/31/2022 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 123,043 shares
@ $14.2106, valued at
$1.7M
Bought 35,793 shares
@ $14.7828, valued at
$529.1k
Bought 90,372 shares
@ $14.2106, valued at
$1.3M
Bought 26,353 shares
@ $14.7828, valued at
$389.6k
Bought 10,642 shares
@ $14.2106, valued at
$151.2k
Bought 3,223 shares
@ $14.7828, valued at
$47.6k
|
|
| 05/24/2022 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 5,883 shares
@ $13.9994, valued at
$82.4k
Bought 4,180 shares
@ $13.9994, valued at
$58.5k
Bought 37 shares
@ $13.9994, valued at
$518 |
|
| 05/20/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 8,996 options to buy
@ $17.86, valued at
$160.7k
|
|
| 05/20/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Bought 224,388 shares
@ $8.5, valued at
$1.9M
Bought 189,882 shares
@ $8.5, valued at
$1.6M
Bought 5,730 shares
@ $8.5, valued at
$48.7k
|
|
| 05/16/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Bought 542,999 shares
@ $9.06, valued at
$4.9M
Bought 53,598 shares
@ $9.135, valued at
$489.6k
Bought 457,001 shares
@ $9.06, valued at
$4.1M
Bought 38,558 shares
@ $9.135, valued at
$352.2k
Bought 17,744 shares
@ $9.135, valued at
$162.1k
|
|
| 05/09/2022 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 75,495 shares
@ $19.5991, valued at
$1.5M
Bought 55,210 shares
@ $19.255, valued at
$1.1M
Bought 70,439 shares
@ $19.5991, valued at
$1.4M
Bought 40,659 shares
@ $19.255, valued at
$782.9k
Bought 4,066 shares
@ $19.5991, valued at
$79.7k
Bought 4,131 shares
@ $19.255, valued at
$79.5k
|
|
| 04/05/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Bought 266,598 shares
@ $10.7499, valued at
$2.9M
Bought 9,402 shares
@ $10.7499, valued at
$101.1k
|
|
| 03/11/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on CTI BIOPHARMA CORP|
Txns:
| Granted 80,000 options to buy
@ $4.49, valued at
$359.2k
|
|
| 01/31/2022 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 58,042 shares
@ $38.3319, valued at
$2.2M
Bought 20,085 shares
@ $40.7, valued at
$817.5k
Bought 37,859 shares
@ $38.3319, valued at
$1.5M
Bought 14,323 shares
@ $40.7, valued at
$582.9k
|
|
| 01/26/2022 |
4
| BVF PARTNERS L P/IL (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Bought 158,041 shares
@ $37.7635, valued at
$6M
Bought 114,726 shares
@ $37.7635, valued at
$4.3M
|
|
| 01/21/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Bought 577,798 shares
@ $14.1, valued at
$8.1M
Bought 412,264 shares
@ $14.1, valued at
$5.8M
Bought 7,899 shares
@ $14.1, valued at
$111.4k
|
|
| 01/10/2022 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 255,500 shares
@ $12, valued at
$3.1M
Bought 61,343 shares
@ $11.9984, valued at
$736k
Bought 226,079 shares
@ $12, valued at
$2.7M
Bought 14,806 shares
@ $12, valued at
$177.7k
|
|
| 12/02/2021 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Bought 362,430 shares
@ $9.3903, valued at
$3.4M
Bought 341,977 shares
@ $9.3903, valued at
$3.2M
Bought 35,268 shares
@ $9.3903, valued at
$331.2k
|
|
| 10/08/2021 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Merus N.V.|
Txns:
| Sold 530,999 shares
@ $27.5311, valued at
$14.6M
Sold 80,011 shares
@ $27.7865, valued at
$2.2M
Sold 384,914 shares
@ $27.5311, valued at
$10.6M
Sold 58,327 shares
@ $27.7865, valued at
$1.6M
Sold 69,534 shares
@ $27.5311, valued at
$1.9M
Sold 8,929 shares
@ $27.7865, valued at
$248.1k
|
|
| 09/23/2021 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 6,341 shares
@ $13.9426, valued at
$88.4k
Bought 4,102 shares
@ $13.9426, valued at
$57.2k
Bought 590 shares
@ $13.9426, valued at
$8.2k
|
|
| 09/15/2021 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Bought 213,246 shares
@ $16.49, valued at
$3.5M
Bought 158,511 shares
@ $16.49, valued at
$2.6M
Bought 20,512 shares
@ $16.49, valued at
$338.2k
|
|
|
|
|